Cargando…
Exome-Sequence Analyses of Four Multi-Incident Multiple Sclerosis Families
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the Central Nervous System (CNS). Currently, it is estimated that 30–40% of the phenotypic variability of MS can be explained by genetic factors. However, low susceptibility variants identified through Genome Wide Association Study...
Autores principales: | Zrzavy, Tobias, Leutmezer, Fritz, Kristoferitsch, Wolfgang, Kornek, Barbara, Schneider, Christine, Rommer, Paulus, Berger, Thomas, Zimprich, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563748/ https://www.ncbi.nlm.nih.gov/pubmed/32854198 http://dx.doi.org/10.3390/genes11090988 |
Ejemplares similares
-
Feasibility of a smartphone app to monitor patient reported outcomes
in multiple sclerosis: The haMSter interventional trial
por: Altmann, Patrick, et al.
Publicado: (2022) -
Peripheral Hemolysis in Relation to Iron Rim Presence and Brain Volume in Multiple Sclerosis
por: Krajnc, Nik, et al.
Publicado: (2022) -
The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot Study
por: Altmann, Patrick, et al.
Publicado: (2021) -
No Association of Multiple Sclerosis with C9orf72 Hexanucleotide Repeat Size in an Austrian Cohort
por: König, Theresa, et al.
Publicado: (2023) -
Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)
por: Monschein, Tobias, et al.
Publicado: (2023)